FUNDERS

Morning session

9.15 - 10.00 Registration: Tea & coffee

10.00 - 10.05 WelcomeProfessor Sara Marshall, Head of Clinical and Physiological Sciences, Wellcome Trust

The story so farProfessor Sir Rory Collins, Principal Investigator, UK Biobank

10.05 - 10.20

10.20 - 10.30 Streamlining the access processMs Carolyn Low, Head of Access, UK Biobank

Guiding use of the UK Biobank resourceProfessor Martin Bobrow, University of Cambridge and Chair, UK Biobank Access Sub-Committee

10.30 - 10.40

From Ethics & Governance Council to Ethics Advisory CommitteeProfessor Anneke Lucassen, University of Southampton

10.40 - 10.50

Panel: questions10.50 - 11.00

Introduction: GeneticsChair: Professor Gil McVean, University of Oxford

11.00 - 11.05

UK Biobank and the UK Life Sciences Industrial StrategyProfessor Sir John Bell, University of Oxford

11.05 - 11.15

Using genomics to understand an individual’s risk for common diseases Professor Peter Donnelly, Genomics plc

11.15 - 11.30

Identifying the genetic determinants of arrhythmiasProfessor Cristen Willer, University of Michigan

11.30 - 11.45

Associations with haemochromatosis genetic variantsProfessor David Melzer, University of Exeter

11.45 - 11.55

Exome sequencing for drug discovery Professor Jonathan Marchini, Regeneron

11.55 - 12.10

12.10 - 12.25 Why bother to whole genome sequence UK Biobank?Dr Kári Stefánsson, deCODE

12.25 - 12.40 Panel: questions

12.40 - 13.40 Lunch

FUNDERS

Afternoon session

13.40 - 13.45 Introduction: Health outcomesChair: Professor Sir Alex Markham, University of Leeds

13.45 - 13.55 Update on UK Biobank follow-upMs Robin Flaig, University of Edinburgh

13.55 - 14.05 Central linkage processesDr Mark Effingham, Chief Operating Officer, UK Biobank

Strategies for health outcome phenotypingProfessor Cathie Sudlow, Chief Scientist, UK Biobank

14.05 - 14.15

14.15 - 14.30 PheWAS: discovering gene-disease associationsProfessor Josh Denny, Vanderbilt University

14.30 - 14.35 Global challenge for scalable outcome phenotypingProfessor Russ Altman, Stanford University

14.35 - 14.45 Panel: questions

14.45 - 15.10 Early Career Researcher Awards: Winner and 2 Runners-upChair: Professor Naomi Allen, Senior Epidemiologist, UK Biobank

15.10 - 15.30 Afternoon tea

Introduction: Other -omicsChair: Professor Bernard Keavney, University of Manchester

15.30 - 15.35

15.35 - 15.45 Multi-omic approaches to understanding disease mechanismsDr Jimmy Peters, University of Cambridge

15.45 - 16.00 Metabolomics – understanding the biochemical fingerprint of diseaseProfessor Karsten Suhre, Weill Cornell Medicine, Qatar

16.00 - 16.15 Strategies for conducting metabolomics analyses at scaleDr Clary Clish, The Broad Institute

16.15 - 16.30 Approach to large-scale multi-omics in UK BiobankProfessor Tony Whetton, University of Manchester

16.30 - 16.40 UK Biobank Eye & Vision Consortium: making the resource work for researchersProfessor Paul Foster, University College London

16.40 - 16.50 UK Biobank Imaging study: how might this landmark study improve health researchProfessor Paul Matthews, Imperial College London

16.50 - 16.55 Getting the most out of UK BiobankProfessor Rory Collins

16.55 - 17.05 Panel: questions

17.05 - 17.10 Closing remarksProfessor Patrick Chinnery, MRC Clinical Director

17.10 - 18.15 Drinks reception

NOTES

WIFI: QE II Guest - no password required

Download our free event app to connect with fellow attendees: https://whova.com/portal/ubsc_201906/